Cargando…
Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling
This study examined rates of genetic testing in two cohorts of publicly insured individuals who have newly prescribed medication with FDA pharmacogenomic labeling guidance. Genetic testing was rare (4.4% and 10.5% in Medicaid and Medicare cohorts, respectively) despite the fact that all participants...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883752/ https://www.ncbi.nlm.nih.gov/pubmed/33589791 http://dx.doi.org/10.1038/s41397-021-00211-1 |